The U.S. government says it will move forward with wider tests of its Zika vaccine after the results from a safety study initiated last summer were promising.
The vaccine, called a DNA vaccine, uses genes from the virus to create an immune response. It was first given to volunteers last August as concern spread over a cluster of Zika cases in Miami.
The new phase of the vaccine tests began Wednesday at Baylor College of Medicine in Houston, one of 11 U.S. locations that will enroll up to 5,000 healthy adults, according to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which developed the vaccine.
In a call with reporters on Friday, Fauci said initial results in 40 volunteers indicate that the vaccine produced an immune response against Zika and didn’t cause serious side effects.
Companies are developing novel DNA vaccines to protect against a range of infections and to treat cancer.
GeneOne Life Science
Flu, hepatitis C
Ichor Medial Systems
HIV, malaria, breast cancer, melanoma
MERS, Ebola, Zika
The threat has waned since Zika spread across Latin America and reached the U.S. last summer, but Fauci cautioned that the virus could return. People who get the mosquito-borne virus generally have only mild symptoms, but infection during pregnancy has been linked to serious birth defects.
The vaccine being tested, as well as other DNA vaccines, contains genetic material from the virus which, once injected into muscle, trains the body to mount an immune response against the virus.
The appeal of DNA vaccines is that they can be designed quickly to counter emerging threats and are easier to manufacture than traditional vaccines. The NIH previously developed a DNA vaccine against West Nile virus, but it was never commercialized.
Companies developing DNA vaccines include Astella Pharma, Inovio Pharmaceuticals, and GeoVax, whose products aim to protect against malaria, peanut allergy, and some types of cancer. So far, however, no DNA vaccine has reached the market.
To prove that the Zika vaccine protects against infection, Fauci says, the trial will eventually be expanded to sites in Puerto Rico, Brazil, Peru, Costa Rica, Panama, and Mexico, where the virus is still being transmitted.
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.